Phase 1 biotech developing T cell immunotherapies for various cancers.
Industry: Health Care
First Day Return: -3.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/27/2018 |
Offer Price | $14.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 5.4 |
Deal Size ($mm) | $76 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/07/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $76 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2015 |
Employees at IPO | 45 |
Website www.harpoontx.com |